- Home
- MRSN vs NIXX Comparison
MRSN vs NIXX Comparison
Compare MRSN & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- NIXX
- Stock Information
- Founded
- MRSN 2001
- NIXX 2010
- Country
- MRSN United States
- NIXX United States
- Employees
- MRSN N/A
- NIXX N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- NIXX
- Sector
- MRSN Health Care
- NIXX
- Exchange
- MRSN Nasdaq
- NIXX NYSE
- Market Cap
- MRSN 71.9M
- NIXX 66.8M
- IPO Year
- MRSN 2017
- NIXX N/A
- Fundamental
- Price
- MRSN $0.53
- NIXX $1.96
- Analyst Decision
- MRSN Buy
- NIXX
- Analyst Count
- MRSN 7
- NIXX 0
- Target Price
- MRSN $6.00
- NIXX N/A
- AVG Volume (30 Days)
- MRSN 5.4M
- NIXX 213.0K
- Earning Date
- MRSN 03-07-2025
- NIXX 04-15-2025
- Dividend Yield
- MRSN N/A
- NIXX N/A
- EPS Growth
- MRSN N/A
- NIXX N/A
- EPS
- MRSN N/A
- NIXX N/A
- Revenue
- MRSN $34,837,000.00
- NIXX $668,693.00
- Revenue This Year
- MRSN N/A
- NIXX $209.13
- Revenue Next Year
- MRSN N/A
- NIXX N/A
- P/E Ratio
- MRSN N/A
- NIXX N/A
- Revenue Growth
- MRSN N/A
- NIXX N/A
- 52 Week Low
- MRSN $0.49
- NIXX $1.20
- 52 Week High
- MRSN $6.28
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- MRSN 32.86
- NIXX N/A
- Support Level
- MRSN $0.56
- NIXX N/A
- Resistance Level
- MRSN $0.82
- NIXX N/A
- Average True Range (ATR)
- MRSN 0.07
- NIXX 0.00
- MACD
- MRSN 0.03
- NIXX 0.00
- Stochastic Oscillator
- MRSN 8.39
- NIXX 0.00
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.